- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07706192
Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts
Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Patients Undergoing Active Treatment
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Massey CTO CPC Team
- Telefonnummer: 804-628-6430
- E-mail: MasseyCPC@vcu.edu
Studiesteder
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23286
- Rekruttering
- Virginia Commonwealth University
-
Ledende efterforsker:
- Susan Hong, MD
-
Kontakt:
- Massey CTO CPC Team
- Telefonnummer: 804-628-6430
- E-mail: MasseyCPC@vcu.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Adult patients (≥18 years old) with a current diagnosis of cancer
- Patients attending outpatient services at the VCU Massey Comprehensive Cancer Center
- Patients who are willing to participate and provide informed consent
- Responding "sometimes true" or "often true" to at least one of the two validate Hunger Vital Sign Screening questions
Exclusion Criteria:
- Patients who are unable to provide informed consent due to cognitive impairment or language barriers
- Patients who are enrolled in other clinical trials that prohibit participation in additional research
- Patients who do not consent to being included in the food insecurity registry
- Patients with medical conditions other than cancer
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Food Assistance Program
Six month food assistance program-shelf-stable food boxes
|
Participants will be enrolled and provided with structured food assistance (e.g., shelf stable food boxes, produce vouchers) for six months
Andre navne:
|
|
Aktiv komparator: Standard of Care
Usual-care referrals
|
Participants who receive usual-care referrals but not food packages.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluate the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.
Tidsramme: 6 months following enrollment
|
Percent of participants that self-report of treatment completion
|
6 months following enrollment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Food Insecurity Score
Tidsramme: Baseline and 6 month follow-up
|
Using the Food Insecurity Assessment: a 2 Question Hunger Vital Signs will be used to assess patient food insecurity status with the following two questions: "Within the past 12 months, did you worry your food would run out before you got the money to buy more?" "Within the past 12 months, did the food you buy not last and you didn't have money to get more?" Scoring will categorize patients as never true, sometimes true, or often true. Baseline is defined as when a patient responds SOMETIMES TRUE or OFTEN TRUE to one of the two validated Hunger Vital Sign Screening questions for the first time. Patients will receive an email about the financial impact and QOL validated surveys at each time interval. |
Baseline and 6 month follow-up
|
|
Change in Quality of Life (QOL) using European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-30)
Tidsramme: Baseline and 6 month follow-up
|
The EORTC QLQ-30 questionnaire is a 30-item, patient-reported instrument designed to assess the health-related quality of life (HRQoL), functional status, and symptom burden of cancer patients. Comprises 30 questions grouped into 5 functional scales, 9 symptom scales/items, and a global health status. Scoring: Uses a 4-point Likert scale (7-point for global items), transformed to a 0-100 scale. Higher scores indicate better function/QoL, but worse symptom burden. |
Baseline and 6 month follow-up
|
|
Change in financial toxicity
Tidsramme: Baseline and 6 month follow-up
|
The Functional Assessment of Chronic Illness Therapy for measure of financial toxicity (FACIT-COST) questionnaire to assess the impact of treatment on patient financial status.
This measure has 12 questions based on patient reported outcomes to assess financial quality of life stress; numeric responses 0-4; Uses a score range 0-44 with higher scores indicating better Financial Well-Being.
|
Baseline and 6 month follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Susan Hong, MD, Virginia Commonwealth University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Opførsel
- Sundhedsadfærd
- Behandlingsoverholdelse og compliance
- Sundhedstjenester Administration
- Sundhedsvæsenets kvalitet, adgang og evaluering
- Sundhedskvalitet
- Kvalitetsindikatorer, sundhedsvæsenet
- Sundhedsøkonomi og organisationer
- Offentlig hjælp
- Finansiering, regering
- Finansiering, organiseret
- Økonomi
- Standard for pleje
- Madhjælp
Andre undersøgelses-id-numre
- MCC-25-22644
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Behandlingsoverholdelse
-
University of OxfordMedical Research Council; P1vital Products LimitedAfsluttetEmotion | Bright Light Treatment | AnsigtsudtryksgenkendelseDet Forenede Kongerige
-
Soroka University Medical CenterAfsluttetOptimering af Second Line Treatment Protocol for H Pylori-udryddelseIsrael
-
Tel Aviv UniversityRekrutteringPlacebo effekt | Social angstlidelse (SAD) | Attention Bias Modification Treatment (ABMT)Israel
-
Peking University Sixth HospitalRekrutteringKognitiv svækkelse | Major Depressive Disorder (MDD) | Neuroimaging | Bright Light TreatmentKina
-
New York State Psychiatric InstituteAfsluttetAfdækning af neurale og immune mekanismer for kroniske smerter i efterbehandling Lyme syndrom (PTLS)Kronisk smerte | Post Treatment Lyme Syndrome (PTLS)Forenede Stater
-
Tel Aviv UniversityAfsluttetAttention Bias Modification Treatment (ABMT)Israel
Kliniske forsøg med Food Assistance Program
-
Medical University of South CarolinaWW InternationalAfsluttetFedme | VægttabForenede Stater
-
International Food Policy Research InstituteHelen Keller International; Foreign Affairs, Trade and Development, CanadaAfsluttetOprettelse af Homestead Agriculture for Nutrition and Gender Equity (CHANGE) i Burkina Faso (CHANGE)Anæmi | VæksthæmningBurkina Faso
-
The Hospital for Sick ChildrenRyerson UniversityRekruttering
-
The University of Texas Health Science Center at...Louise L Morrison TrustAfsluttetKronisk sygdom | Ernæring, sundForenede Stater
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RekrutteringErnæring, sundForenede Stater
-
Dana-Farber Cancer InstituteRekrutteringBarnekræft | Overlevende af børnekræftForenede Stater
-
Wake Forest University Health SciencesAfsluttet
-
Sabine GabryschGerman Research Foundation; German Federal Ministry of Education and Research og andre samarbejdspartnereAfsluttet
-
Columbia UniversityNational Institute of Nursing Research (NINR)Suspenderet
-
Purdue UniversityAfsluttetJernmangel | A-vitamin mangelSenegal